Edition:
United States

Claris Lifesciences Ltd (CLAI.BO)

CLAI.BO on Bombay Stock Exchange

313.05INR
5:14am EST
Change (% chg)

Rs1.80 (+0.58%)
Prev Close
Rs311.25
Open
Rs315.80
Day's High
Rs317.20
Day's Low
Rs310.50
Volume
42,056
Avg. Vol
270,763
52-wk High
Rs430.10
52-wk Low
Rs126.10

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -- March 18 Jan 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 0
(2) OUTPERFORM 0 0 0 0
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.50 2.50 2.50 4.00

Consensus Estimates Analysis

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Year Ending Mar-17 1 8,287.00 8,287.00 8,287.00 8,312.75
Year Ending Mar-18 1 10,806.00 10,806.00 10,806.00 --
Earnings (per share)
Year Ending Mar-17 1 22.80 22.80 22.80 27.72
Year Ending Mar-18 1 34.20 34.20 34.20 --

Historical Surprises

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-15 1,737.13 2,005.24 268.11 15.43
Quarter Ending Dec-12 2,021.00 1,935.87 85.13 4.21
Quarter Ending Sep-12 2,200.00 1,939.10 260.90 11.86
Quarter Ending Sep-11 2,303.00 2,040.86 262.14 11.38
Earnings (per share)
Quarter Ending Jun-15 2.86 3.72 0.86 30.07
Quarter Ending Sep-11 8.20 5.33 2.87 35.00

Consensus Estimates Trend

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Year Ending Mar-17 8,287.00 8,287.00 8,287.00 8,287.00 8,312.75
Year Ending Mar-18 10,806.00 10,806.00 10,806.00 10,806.00 --
Earnings (per share)
Year Ending Mar-17 22.80 22.80 22.80 22.80 27.72
Year Ending Mar-18 34.20 34.20 34.20 34.20 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Year Ending Mar-17 0 0 0 0
Year Ending Mar-18 0 0 0 0
Earnings
Year Ending Mar-17 0 0 0 0
Year Ending Mar-18 0 0 0 0